<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"modified radical neck dissection":1,
"papillary thyroid carcinoma":9,
"robotic":1,
"Aerobic glycolysis":1,
"Cancer metabolism":2,
"Cell signalling":1,
"PKM2":1,
"calcitonin":2,
"liver":1,
"medullary thyroid carcinoma":2,
"metastasis":3,
"thyroid":12,
"Ablación":1,
"Ablation":1,
"Bajo riesgo":1,
"Cáncer diferenciado de tiroides":1,
"Differentiated thyroid cancer":2,
"Iodine-131":1,
"Low risk":1,
"Medicina personalizada":1,
"Personalized medicine":1,
"Radioiodine":1,
"Radioyodo":1,
"Yodo-131":1,
"Recurrence":2,
"Thyroid-stimulating hormone pituitary adenoma":1,
"Thyrotroph adenoma":1,
"Transsphenoidal surgery":1,
"cat":1,
"feline":1,
"hyperthyroidism":2,
"scintigraphy":1,
"CTLA-4":1,
"GVAX":1,
"immunotherapy":1,
"thyroglobulin antibodies":1,
"molecular diagnosis":1,
"next-generation sequencing":1,
"thyroid FNA":1,
"thyroid cancer":14,
"Bethesda System":2,
"FNA":1,
"atypia":1,
"undetermined significance":1,
"dog":2,
"hypercalcemia":1,
"incidental":1,
"tumor":2,
"ultrasound":2,
"MEN 2A":1,
"MEN 2B":1,
"familial MTC":1,
"medullary thyroid cancer":3,
"prophylactic thyroidectomy":2,
"Thyroid nodule size":1,
"fine-needle aspiration biopsy":1,
"systematic review":1,
"thyroid malignancy":1,
"thyroid neoplasia":1,
"Ecological study":1,
"Pennsylvania":1,
"geospatial clustering":1,
"radon":1,
"Cáncer de tiroides":1,
"Enfermedad nodular tiroidea":1,
"Hormona paratiroidea":1,
"Nodular thyroid disease":1,
"TSH":1,
"Hemithyroidectomy":1,
"Hypothyroidism":3,
"Thyroid lobectomy":1,
"Thyroid-stimulating hormone":1,
"BRAF":3,
"genomic medicine":1,
"prognosis":2,
"General Paediatrics":1,
"Genetics":2,
"Neurodevelopment":1,
"Oncology":3,
"Iodine-supported spinal instrument":1,
"Multivariate analysis":1,
"Risk factor":1,
"Surgical site infection":1,
"Total en bloc spondylectomy":1,
"Vertebral tumor":1,
"Anaplastic thyroid carcinoma":1,
"Oncolytic virus":1,
"PARP inhibitors":1,
"Breast neoplasms":1,
"Conformal radiotherapy":1,
"Partial breast irradiation":1,
"molecular targeted therapy":1,
"thyroid nodule":3,
"Ampliamente invasivo":1,
"Carcinoma folicular":1,
"Diferenciación":1,
"Differentiation":1,
"Factores pronósticos":1,
"Follicular carcinoma":1,
"Invasion":1,
"Invasive":1,
"Invasión":1,
"Minimally invasive":1,
"Mínimamente invasivo":1,
"Prognostic factors":2,
"Thyroid gland":2,
"Tiroides":1,
"Captación":1,
"I-131":1,
"Rastreo de cuerpo completo":1,
"Thymus":1,
"Timo":1,
"Uptake":1,
"Whole body scan":1,
"Human chorionic gonadotrophin":1,
"Thyroid papillary cancer":1,
"hCG immunoassays":1,
"ataxia telangiectasia mutated":1,
"genetic polymorphism":1,
"single nucleotide polymorphism":1,
"molecular docking":1,
"pharmacophore":1,
"pyruvate kinase":1,
"virtual screening":1,
"Republic of Korea":1,
"adult":1,
"risk":1,
"second malignancy":1,
"thyroid neoplasm":2,
"Anti-angiogenetic therapy":1,
"Cancer therapy":1,
"Kinase inhibitors":1,
"Protein kinases":1,
"Classifier":1,
"Follicular thyroid adenoma":1,
"Follicular thyroid cancer":1,
"Anatomy":1,
"Fenestration":1,
"Internal jugular vein":1,
"Neck dissection":1,
"Surgery":1,
"Variation":1,
"Auger electrons":1,
"androgen receptor":1,
"molecular radiotherapy":1,
"prostate cancer":1,
"theranostic":1,
"Elderly":1,
"Remission":1,
"CTC":1,
"Circulating tumour cells":1,
"EpCAM":1,
"TSH-R":1,
"Tg":1,
"mRNA":1,
"Apoptosis":2,
"Foxp3":1,
"PPARγ":1,
"Akt":1,
"Immunohistochemistry":4,
"MiR-21":1,
"PDCD4":1,
"Thyroid cancer, papillary":1,
"Thyroid neoplasms":2,
"Thyroiditis":1,
"Ultrasonography":2,
"Burkitt's lymphoma":1,
"diagnostic genomics":1,
"gastrointestinal stromal tumors":1,
"genetic testing":1,
"hereditary thyroid cancer":1,
"multiple endocrine neoplasia":1,
"nonmedullary thyroid cancer":1,
"ret proto oncogene":1,
"dental implants":1,
"effective dose":1,
"lifetime-attributable risk":1,
"mandible":1,
"maxilla":1,
"adenocarcinoma":1,
"adenoid cystic carcinoma":1,
"cytology":3,
"fine-needle aspiration":1,
"lymphoma":3,
"renal cell carcinoma":3,
"secondary neoplasm":1,
"squamous cell carcinoma":2,
"fine Needle aspiration":1,
"granular cell tumor":1,
"Otolaryngology":1,
"central neck dissection":1,
"hypoparathyroidism":1,
"total thyroidectomy":1,
"vocal cord paralysis":1,
"breast cancer":2,
"diagnose":1,
"mechanism":1,
"synchronous neoplasms":1,
"CCND1 gene":1,
"cancer susceptibility alleles with low penetrance":1,
"differentiated thyroid carcinoma":2,
"malignant melanoma":1,
"TPO":1,
"thyroid peroxidase":1,
"Adrenal cysts":1,
"Adrenal tumors":1,
"Adrenalectomy":1,
"Epidemiology":2,
"Genomics":1,
"Outcome":1,
"RAS":1,
"TERT":1,
"(18)F-fluorodeoxyglucose":1,
"FDG":1,
"Head and neck":1,
"PET/CT":2,
"Positron emission tomography/computer tomography":1,
"MicroRNA":2,
"Papillary thyroid cancer":1,
"Plasma":1,
"Tumor size":1,
"Activator regenerated by electron transfer–atom transfer radical polymerization (ARGET–ATRP)":1,
"Biomarker-sensor":1,
"Surface imprinting":1,
"Zinc oxide nanostructure":1,
"Diagnostic device":1,
"Fine Needle Elastography":1,
"Needle penetration":1,
"Piezoelectric sensor":1,
"Tissue biomechanics":1,
"DNA methylation":1,
"epigenetic":1,
"esophageal neoplasms":1,
"esophagectomy":1,
"hand video-assisted thoracoscopic surgery":1,
"quality of life":1,
"CXC195":1,
"Hepatocellular carcinoma":1,
"Inflammation":1,
"NF-κB":1,
"Proliferation":1,
"TLR4":1,
"CT":1,
"Incidental thyroid nodule":1,
"MR imaging":1,
"Radioactive iodine scan":1,
"Cancer":4,
"Nodules":1,
"Pediatrics":1,
"Therapeutics":1,
"antagonist":1,
"cancer imaging":1,
"cholecystokinin 2/gastrin receptor":1,
"nonpeptide":1,
"radioimaging of tumors":1,
"tumor-targeted therapy":1,
"p66Shc":1,
"reactive oxygen species":1,
"15O-water":1,
"62Cu PET":1,
"62Cu-ETS [ethylglyoxal bis(thiosemicarbazonato)copper(II)]":1,
"tumor perfusion":1,
"B-cell NHL":1,
"autoimmunity":1,
"cryoglobulinemia":1,
"cryoglobulinemic vasculitis":1,
"diabetes":1,
"hepatitis C virus":1,
"mixed cryoglobulinemia":1,
"pathology":2,
"sonography":3,
"anteroposterior-to-transverse ratio":1,
"nodule size":1,
"Childhood Cancer Survivors":1,
"External radiotherapy":1,
"Radiation damage":1,
"Thyroid ultrasonography":1,
"Organ Preservation":1,
"cell culture":1,
"prazosin":1,
"quinazolines":1,
"α1-adrenergic receptors":1,
"miR-15a":1,
"levothyroxine substitution therapy":1,
"sunitinib":1,
"thiamazole antithyroid therapy":1,
"thyrotoxicosis":1,
"RAS/RAF/mitogen-activated protein kinase":1,
"angiogenesis":1,
"phosphatidylinositide 3-kinase/Akt/mammalian target of rapamycin":1,
"targeted agents":1,
"thyroid carcinoma":2,
"codon optimization":1,
"gene therapy":1,
"human sodium iodide symporter (hNIS)":1,
"radioiodine therapy":1,
"reporter":1,
"Claudin-1 (CLDN-1)":1,
"canine":1,
"thyroid tumors":1,
"188Re":1,
"bioluminescent imaging":1,
"glioma":1,
"liposome":1,
"radionuclide therapy":1,
"Cortical-sparing adrenalectomy":1,
"Multiple endocrine neoplasia type 2":1,
"Mutation screening":1,
"RET":1,
"Gastric serosa":1,
"Lung adenocarcinoma":1,
"Malignant":1,
"Metastatic carcinoma":1,
"Perivascular epithelioid cell tumor":1,
"Struma Ovarii":1,
"Thyroidectomy":1,
"CD147":1,
"RNA interference":1,
"Thyroid cancer-experimental":1,
"glycolysis":1,
"pathology-thyroid":1,
"Epithelial-mesenchymal transition (EMT)":1,
"anaplastic thyroid carcinoma (ATC)":1,
"cancer stem cell":1,
"intratumor heterogeneity":1,
"lymph node metastasis":1,
"Common variable immunodeficiency patients":1,
"Neoplasm":1,
"IMP3":1,
"Vitamin D":1,
"dietary products":1,
"selenium":1,
"biopsy":1,
"fine needle":1,
"multicenter study":1,
"terminology":1,
"thyroid cytopathology":1,
"hyperparathyroidism":1,
"parathyroid adenoma":1,
"parathyroidectomy":1,
"anaplastic carcinoma":1,
"gastric metastasis":1,
"skin metastasis":1,
"Cribriform variant":1,
"Papillary carcinoma":1,
"Oncología":1,
"PET/MR":1,
"PET/RM":1,
"PET/RM simultánea":1,
"PET/TC":1,
"Positron emission tomography":1,
"Simultaneous PET/MRI":1,
"Tomografía por emisión de positrones":1,
"Hyperprolactinemia":1,
"prolactinoma":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2015年1月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
